Latest filing published 18 Mar 2024 for BALAXI PHARMACEUTICALS LIMITED, €19k.
Insider track record
No signal scores available.
Mangina Srinivas Rao: trading record in brief
This profile gathers the share dealings of Mangina Srinivas Rao in Balaxi Pharmaceuticals Limited. In total, 5 filings cover trades dated from 11 October 2022 to 15 March 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 March 2024 came the latest disclosure, a transaction for €19k in Balaxi Pharmaceuticals Limited. Filings reach the SEBI (PIT + SAST) feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Mangina Srinivas Rao
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ ₹338.2536.1% of flowWarrantsSEBI:5d9e4656eceefa8975abcdab7c479c61849462d1
- 5,000 shares@ ₹338.2536.7% of flowEquity SharesSEBI:8719626a56b4072f3dc6f0018a6659d669240304
- 10,000 shares@ ₹112.7527.2% of flowWarrantsSEBI:ac2fd0330cd6735a2ed34fa17f87ac02c529a755
3 of 3 declarations